Related Experiment Video

Updated: Jun 9, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
07:56

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts

Published on: January 29, 2018

American Academy of Pediatrics. Policy statement--child fatality review

, ,

    Pediatrics
    |September 1, 2010
    PubMed

    Insights

    Child fatality review teams prevent deaths by analyzing child mortality data. This public health approach identifies effective strategies to reduce preventable child deaths across all age groups.

    Area of Science:

    • Public Health
    • Epidemiology
    • Pediatrics

    Background:

    • Injury is the primary cause of death in children.
    • Child fatality review teams initially focused on abuse/neglect.
    • The scope has broadened to a public health model for all child deaths.

    Purpose of the Study:

    • To highlight the expanded role of child fatality review teams.
    • To emphasize their utility in preventing child mortality.
    • To advocate for enhanced review processes and pediatrician involvement.

    Main Methods:

    • Systematic review of child deaths from birth through adolescence.
    • Analysis of data from approximately half of all states.
    • Identification of local and state prevention strategies.

    Main Results:

    • Fatality review processes have identified effective prevention strategies.
    • The expanded approach aids in understanding child death epidemiology and preventability.
    • Improved accuracy of vital statistics data is a key outcome.

    Conclusions:

    • Child fatality review is a powerful public health tool.
    • It informs public health and legislative strategies for reducing preventable deaths.
    • The American Academy of Pediatrics supports legislative enhancement and pediatrician engagement.

    More Related Videos

    Assessment of Child Anthropometry in a Large Epidemiologic Study09:36

    Assessment of Child Anthropometry in a Large Epidemiologic Study

    Published on: February 2, 2017

    Guidelines for Elective Pediatric Fiberoptic Intubation11:19

    Guidelines for Elective Pediatric Fiberoptic Intubation

    Published on: January 17, 2011

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    Drug Regulation01:25

    Drug Regulation

    Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...